Sex-stratified immune patterns across the canine lifespan and short-term responses to geroprotective interventions.
Key claim: Laboratory Beagles show heterogeneous, non-linear immune aging with sex-stratified cytokine patterns, and short-term rapamycin produced the broadest exploratory cytokine response among rapamycin, canagliflozin, and dietary restriction.
Abstract
Canine models are invaluable for translational geroscience, but natural sex-associated immune aging remains under investigated. Here, we characterize the age-associated hematologic and serum cytokine profiles in a controlled cross-sectional cohort of 80 intact laboratory Beagles spanning 1 to 11 years of age. Canine immune aging is heterogeneous and non-linear. While several absolute leukocyte counts declined with age before rising again in geriatric dogs, serum cytokines exhibited distinct, sex-stratified patterns. Although more cytokines varied significantly with age in males than in females, formal age-by-sex interactions did not remain significant after false discovery rate correction. To explore short-term geroprotective responses, we evaluated 24 young beagles following a 90-day intervention with rapamycin, canagliflozin, or dietary restriction. Rapamycin was associated with the broadest endpoint cytokine response. Canagliflozin showed narrower cytokine differences alongside descriptive body-weight reduction, whereas dietary restriction reduced body weight without altering measured immune endpoints. Given the small group sizes and endpoint-only cytokine measurements, these intervention findings remain exploratory and hypothesis-generating. Together, our findings describe stage-specific hematologic changes and sex-stratified cytokine patterns across the canine lifespan and provide a basis for future longitudinal studies.
Why this matters
Dogs sit between rodents and humans as a translational aging model, and this study is one of the first to characterize canine immune aging across the lifespan with sex stratification rather than treating sex as noise. It also delivers a small head-to-head exploratory cytokine comparison of three canonical geroprotectors (rapamycin, canagliflozin, dietary restriction) in a companion mammal, nominating rapamycin as the broadest immune-signal mover on a 90-day timescale before any outcome data.